zyvox
pfizer new zealand limited - linezolid 2 mg/ml - solution for infusion - 2 mg/ml - active: linezolid 2 mg/ml excipient: citric acid glucose monohydrate hydrochloric acid sodium citrate dihydrate sodium hydroxide - zyvox is indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: · pneumonia - community acquired and nosocomial pneumonia · skin and soft tissue infections · enterococcal infections. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected. consideration should be given to official guidance on the appropriate use of antibacterial agents.
vaminolact solution for infusion, 100 ml bottle
fresenius kabi limited - cysteine; tryptophan; glutamic acid; tyrosine; histidine; alanine; phenylalanine; leucine; aspartic acid; lysine; arginine; threonine; serine; taurine; valine; proline; methionine; glycine; isoleucine - solution for infusion - 100 millilitre(s) - solutions for parenteral nutrition; amino acids
triomel 7g/l nitrogen 1140kcal/l, emulsion for infusion
baxter healthcare limited - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - emulsion for infusion - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - blood substitutes and perfusion solutions
triomel 9g/l nitrogen 1070kcal/l, emulsion for infusion
baxter healthcare limited - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - emulsion for infusion - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate 250 g; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - blood substitutes and perfusion solutions
vamin 18 electrolyte-free
fresenius kabi limited - phenylalanine; arginine; aspartic acid; alanine; threonine; valine; glutamic acid; glycine; isoleucine; l-lysine; l-methionine; l-tryptophan; l-tyrosine; serine; l-cysteine; leucine; l-histidine; proline - solution for infusion - phenylalanine 7.9 g/l; arginine 11.3 g/l; aspartic acid 3.4 g/l; alanine 16 g/l; threonine 5.6 g/l; valine 7.3 g/l; glutamic acid 5.6 g/l; glycine 7.9 g/l; isoleucine 5.6 g/l; l-lysine 9 g/l; l-methionine 5.6 g/l; l-tryptophan 1.9 g/l; l-tyrosine 230 mg/l; serine 4.5 g/l; l-cysteine 560 mg/g; leucine 7.9 g/l; l-histidine 6.8 g/l; proline 6.8 g/l - blood substitutes and perfusion solutions
ganfort pf 0.3/5
abbvie limited - bimatoprost 300 µg/ml; ; timolol maleate 5 mg/ml; - eye drops, solution - 300mcg/ml & 5mg/ml - active: bimatoprost 300 µg/ml timolol maleate 5 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.
physioneal 40 glucose 1.36% w/v/13.6 mg/ml clear-flex
vantive limited - calcium chloride dihydrate 0.184 g/l; ; ; glucose monohydrate 15 g/l equivalent to anhydrous glucose 13.6 g/l; ; magnesium chloride hexahydrate 0.051 g/l; ; sodium bicarbonate 2.1 g/l; ; sodium chloride 5.38 g/l; sodium lactate 1.68 g/l - dialysis solution - active: calcium chloride dihydrate 0.184 g/l glucose monohydrate 15 g/l equivalent to anhydrous glucose 13.6 g/l magnesium chloride hexahydrate 0.051 g/l sodium bicarbonate 2.1 g/l sodium chloride 5.38 g/l sodium lactate 1.68 g/l excipient: hydrochloric acid sodium hydroxide water for injection - for use in peritoneal dialysis in patients with acute or chronic kidney failure
physioneal 40 glucose 3.86% w/v/38.6 mg/ml clear-flex
vantive limited - calcium chloride dihydrate 0.184 g/l; ; ; glucose monohydrate 42.5 g/l equivalent to anhydrous glucose 38.6 g/l; ; magnesium chloride hexahydrate 0.051 g/l; ; sodium bicarbonate 2.1 g/l; ; sodium chloride 5.38 g/l; sodium lactate 1.68 g/l - dialysis solution - active: calcium chloride dihydrate 0.184 g/l glucose monohydrate 42.5 g/l equivalent to anhydrous glucose 38.6 g/l magnesium chloride hexahydrate 0.051 g/l sodium bicarbonate 2.1 g/l sodium chloride 5.38 g/l sodium lactate 1.68 g/l excipient: hydrochloric acid sodium hydroxide water for injection - for use in peritoneal dialysis in patients with acute or chronic kidney failure
ganfort pf 0.3/5 bimatoprost 0.3 mg/ml and timolol (as maleate) 5.0 mg/ml eye drops
abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; hydrochloric acid; citric acid monohydrate; purified water; sodium chloride; sodium hydroxide - ganfort pf 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.
physioneal 40 glucose 1.36% w/v 13.6mg/ml solution for peritoneal dialysis
baxter corporation - dextrose; calcium chloride; magnesium chloride; sodium chloride; sodium bicarbonate; sodium lactate - solution - 37.5g; 0.507g; 0.14g; 8.43g; 3.29g; 2.63g - dextrose 37.5g; calcium chloride 0.507g; magnesium chloride 0.14g; sodium chloride 8.43g; sodium bicarbonate 3.29g; sodium lactate 2.63g - hemodialysis solution